Author:
Dómine Manuel,Massuti Bartomeu,Puente Javier,Calles Antonio,Esteban Emilio,Triguboff Eduardo,Afonzo Yashmin Silvana,Gironés Regina,Aparisi Francisco,Oramas Juana
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference26 articles.
1. Sociedad Española de Oncología Médica (SEOM). Las Cifras del Cáncer en España 2019. SEOM.
https://seom.org/dmcancer/wp-content/uploads/2019/informe-SEOM-cifras-cancer-2019.pdf
.
2. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361:947–57.
3. Shaw AT, Kim DW, Nakagawa K, et al. Crizotinib vs. chemotherapy in advanced ALK-positive lung cancer. N Engl J Med. 2013;368:2385–94.
4. Solomon BJ, Mok T, Kim DW, et al. First line crizotinib vs. chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014;371:2167–77.
5. Shaw AT, Ou SH, Bang YJ, et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2014;371:1963–71.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献